The recommended dosage regimen for caspofungin in patients with higher body weight or hypoalbuminaemia will result in low exposure: Five years of data based on a population pharmacokinetic model and Monte-Carlo simulations.
Front Pharmacol
; 13: 993330, 2022.
Article
en En
| MEDLINE
| ID: mdl-36408257
Texto completo:
1
Base de datos:
MEDLINE
Idioma:
En
Revista:
Front Pharmacol
Año:
2022
Tipo del documento:
Article